SCHEMBL7428103

SCHEMBL7428103

[CH2]CC(c1ccc(F)cc1)c1cccnc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.48
EPHX2 P34913 1/20 0.47
CFTR P13569 1/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
GOPC Q9HD26 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CYP19A1 P11511 4/20 0.42
TBXAS1 P24557 1/20 0.42
KCNA5 P22460 5/20 0.42
KCNH2 Q12809 4/20 0.42
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8827578 0.88 CFTR (0.59) EPHX2CFTRSLC6A2SLC6A4SLC6A3
SCHEMBL7878877 0.88 CFTR (0.57) CFTRSLC6A2SLC6A4SLC6A3GOPC
Ammonia Solution, Strong SCHEMBL5999435 0.82 POLB (0.50) POLBEPHX2CFTRSLC6A2SLC6A4
SCHEMBL7430169 0.82 CYP19A1 (0.44) POLBSLC6A4SMN1; SMN2LMNAHTT
SCHEMBL7289084 0.81 HRH1 (0.52) POLBEPHX2CFTRSLC6A2SLC6A4
SCHEMBL1283383 0.80 IDO1 (0.41) LMNACYP19A1
SCHEMBL4197953 0.78 KCNA5 (0.50) POLBCFTRSLC6A2SLC6A4SLC6A3
SCHEMBL7810718 0.77 TBXAS1 (0.53) POLBEPHX2CFTRSLC6A2SLC6A4
SCHEMBL9030394 0.77 TBXAS1 (0.57) POLBEPHX2CFTRSLC6A2SLC6A4
SCHEMBL1378412 0.77 KCNA5 (0.56) POLBEPHX2CFTRSLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0448765-B1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity HEUMANN PHARMA GMBH & CO (DE) 1994-08-17 EP claimed
WO-1992022295-A1 USE OF GUANIDINE DERIVATIVES IN THE PREPARATION OF A DRUG FOR THE TREATMENT OF SEPSIS AND SEPSIS-LIKE CONDITIONS AND SEPTIC SHOCK NEUGEBAUER EDMUND (DE) 1992-12-23 WO claimed
EP-0448765-A1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity HEUMANN PHARMA GMBH & CO (DE) 1991-10-02 EP claimed
EP-0448765-B1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity HEUMANN PHARMA GMBH & CO (DE) 1994-08-17 EP disclosed
WO-1992022295-A1 USE OF GUANIDINE DERIVATIVES IN THE PREPARATION OF A DRUG FOR THE TREATMENT OF SEPSIS AND SEPSIS-LIKE CONDITIONS AND SEPTIC SHOCK NEUGEBAUER EDMUND (DE) 1992-12-23 WO disclosed
EP-0448765-A1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity HEUMANN PHARMA GMBH & CO (DE) 1991-10-02 EP disclosed